Improvement of Clinical Staging in Cervical Cancer with Serum Squamous Cell Carcinoma Antigen and CA 125 Determinations

Author： Massuger L.F.A.G.   Koper N.P.   Thomas C.M.G.   Dom K.E.L.   Schijf C.P.T.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.64, Iss.3, 1997-03, pp. : 473-476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Clinical Application of Serum Squamous Cell Carcinoma Antigen Level Monitoring in Invasive Cervical Carcinoma

By Maiman M.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 4-6

Elsevier

Access to resources Recommend Favorite

Monitoring of Serum Squamous Cell Carcinoma Antigen Levels in Invasive Cervical Cancer: Is It Cost-Effective?

By Chan Y.M.   Ng T.Y.   Ngan H.Y.S.   Wong L.C.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 7-11

Elsevier

Access to resources Recommend Favorite

The Value of Squamous Cell Carcinoma Antigen as a Predictor of Nodal Metastasis in Cervical Cancer

By Takeshima N.   Hirai Y.   Katase K.   Yano K.   Yamauchi K.   Hasumi K.  

Gynecologic Oncology, Vol. 68, Iss. 3, 1998-03 ,pp. : 263-266

Elsevier

Access to resources Recommend Favorite

Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigenimmunoglobulin M for hepatocellular carcinoma: A metaanalysis

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1165-1171

Science Publishers

Access to resources Recommend Favorite

Can Initial Serum Cyfra 21-1, SCC Antigen, and TPA Levels in Squamous Cell Cervical Cancer Predict Lymph Node Metastases or Prognosis?

By Gaarenstroom K.N.   Kenter G.G.   Bonfrer J.M.G.   Korse C.M.   Van de Vijver M.J.   Fleuren G.-J.   Trimbos J.B.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite